According to an AI flash report, an investor inquired on the interactive platform: What proprietary drug products does your company have? Will you enhance innovation efforts in proprietary drugs? On February 4th, Tibet Aim Pharm. Inc. (002826.SZ) responded on the investor interaction platform, stating the company has no proprietary drug products.
Vast information and precise analysis are available on the Sina Finance App.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments